HF
IMVT icon

HRT Financial’s Immunovant IMVT Stock Holding History

HRT Financial’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.65M Sell
66,485
-18,355
-22% -$475K 0.01% 1741
2025
Q4 		$2.16M Buy
+84,840
New +$1.89M 0.01% 1253
2024
Q1 		– Sell
-92,731
Closed -$3.91M – 2669
2023
Q4 		$3.91M Buy
+92,731
New +$3.41M 0.03% 387
2022
Q4 		– Sell
-143,690
Closed -$801K – 2803
2022
Q3 		$801K Buy
+143,690
New +$702K 0.01% 1070
2022
Q2 		– Sell
-92,945
Closed -$512K – 3308
2022
Q1 		$512K Buy
92,945
+2,066
+2% +$12.9K ﹤0.01% 1619
2021
Q4 		$774K Sell
90,879
-153,002
-63% -$1.26M ﹤0.01% 1344
2021
Q3 		$2.12M Buy
243,881
+65,037
+36% +$587K 0.01% 695
2021
Q2 		$1.89M Buy
+178,844
New +$2.5M 0.02% 654

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return